The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors.
作者信息
Chambers John
机构信息
Cardiothoracic Centre, St Thomas' Hospital, London SE1 7EH, UK.
出版信息
Heart. 2006 Mar;92(3):420-3. doi: 10.1136/hrt.2005.074112.
Abstract
摘要
相似文献
1
The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors.主动脉瓣狭窄时的左心室：使用血管紧张素转换酶抑制剂的证据。
Heart. 2006 Mar;92(3):420-3. doi: 10.1136/hrt.2005.074112.
2
ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity?主动脉瓣狭窄中的血管紧张素转换酶抑制：危险药物还是黄金机遇？
J Hum Hypertens. 2001 Oct;15(10):659-67. doi: 10.1038/sj.jhh.1001260.
3
Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?血管紧张素转换酶抑制剂对主动脉瓣狭窄患者有益吗？
Heart. 2005 Oct;91(10):1257-9. doi: 10.1136/hrt.2004.056614.
4
ACE inhibition in aortic stenosis: an intriguing hypothesis, not a proven therapy.主动脉瓣狭窄中的血管紧张素转换酶抑制：一个有趣的假说，而非已证实的疗法。
J Hum Hypertens. 2001 Oct;15(10):655-7. doi: 10.1038/sj.jhh.1001270.
5
Aortic stenosis and angiotensin-converting enzyme inhibitors--rupture of an ancient paradigm?主动脉瓣狭窄与血管紧张素转换酶抑制剂——古老范例的突破？
Am Heart J. 2005 Feb;149(2):E5; author reply E7. doi: 10.1016/j.ahj.2004.09.044.
6
[Angiotensin-converting-enzyme inhibitor and heart hypertrophy].[血管紧张素转换酶抑制剂与心脏肥大]
Wien Med Wochenschr. 1990 Jan 31;140(1-2):46-9.
7
Why deny ACE inhibitors to patients with aortic stenosis?为什么要拒绝给主动脉瓣狭窄患者使用血管紧张素转换酶抑制剂？
Lancet. 1998 Jul 11;352(9122):111-2. doi: 10.1016/S0140-6736(98)85016-2.
8
[Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].[血管紧张素转换酶基因、糜酶基因与接受血管紧张素转换酶抑制剂治疗患者左心室肥厚消退之间的关联]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Sep;25(9):756-60.
9
Letter regarding article by Rosenhek et al, "statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis".关于罗森赫克等人所著文章《他汀类药物而非血管紧张素转换酶抑制剂可延缓主动脉瓣狭窄进展》的信函
Circulation. 2005 May 3;111(17):e274-5; author reply e274-5. doi: 10.1161/01.CIR.0000163538.27480.03.
10
Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study.血管紧张素转换酶抑制剂对主动脉瓣狭窄高血压患者的影响：一项撤药研究。
Heart. 2005 Oct;91(10):1311-8. doi: 10.1136/hrt.2004.047233.
引用本文的文献
1
Sodium-Glucose Cotransporter 2 Inhibitors in Aortic Stenosis: Toward a Comprehensive Cardiometabolic Approach.钠-葡萄糖协同转运蛋白2抑制剂在主动脉瓣狭窄中的应用：迈向全面的心脏代谢治疗方法
Int J Mol Sci. 2025 May 8;26(10):4494. doi: 10.3390/ijms26104494.
2
Usefulness of Echocardiographic Parameters of Myocardial Work in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术治疗的主动脉瓣狭窄患者中心肌工作超声心动图参数的效用
J Clin Med. 2025 Jan 15;14(2):512. doi: 10.3390/jcm14020512.
3
Left ventricular mass regression after aortic valve replacement with the TTK Chitra™ monoleaflet tilting disc valve.使用TTK Chitra™单叶倾斜盘式瓣膜进行主动脉瓣置换术后左心室质量的消退
Indian J Thorac Cardiovasc Surg. 2023 May;39(3):238-243. doi: 10.1007/s12055-022-01468-2. Epub 2023 Feb 4.
4
Computed tomography and transthoracic echocardiography for assessment of left ventricle geometry in patients with aortic valve stenosis.计算机断层扫描和经胸超声心动图用于评估主动脉瓣狭窄患者的左心室几何形态。
Postepy Kardiol Interwencyjnej. 2023 Mar;19(1):47-55. doi: 10.5114/aic.2023.124406. Epub 2023 Jan 23.
5
Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis.主动脉瓣狭窄的病理生理学、评估新兴技术和新的治疗方法。
Open Heart. 2023 Mar;10(1). doi: 10.1136/openhrt-2022-002244.
6
Insights Into the Metabolic Aspects of Aortic Stenosis With the Use of Magnetic Resonance Imaging.运用磁共振成像技术深入了解主动脉瓣狭窄的代谢方面。
JACC Cardiovasc Imaging. 2022 Dec;15(12):2112-2126. doi: 10.1016/j.jcmg.2022.04.025. Epub 2022 Jun 15.
7
Left ventricular function assessment after aortic and renal intervention in Takayasu arteritis by speckle tracking echocardiography: A pilot study.采用斑点追踪超声心动图评估大动脉炎主动脉和肾干预后左心室功能：一项初步研究。
Indian Heart J. 2022 Mar-Apr;74(2):139-143. doi: 10.1016/j.ihj.2022.02.004. Epub 2022 Feb 23.
8
Clinical impact of myocardial fibrosis in severe aortic stenosis.心肌纤维化在严重主动脉瓣狭窄中的临床影响。
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E147-E150. doi: 10.1093/eurheartj/suab120. eCollection 2021 Oct.
9
Biomechanics of Human Fetal Hearts with Critical Aortic Stenosis.患有严重主动脉瓣狭窄的人类胎儿心脏的生物力学。
Ann Biomed Eng. 2021 May;49(5):1364-1379. doi: 10.1007/s10439-020-02683-x. Epub 2020 Nov 11.
10
The effect of transcatheter aortic valve implantation on Tp-e interval, Tp-e/QT and Tp-e/QTc ratios, and Tp-e dispersion in patients with severe aortic stenosis.经导管主动脉瓣植入术对重度主动脉瓣狭窄患者Tp-e间期、Tp-e/QT及Tp-e/QTc比值和Tp-e离散度的影响。
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Jan 9;26(1):65-72. doi: 10.5606/tgkdc.dergisi.2018.14819. eCollection 2018 Jan.
本文引用的文献
1
Preoperative moderate to severe diastolic dysfunction: a novel Doppler echocardiographic long-term prognostic factor in patients with severe aortic stenosis.术前中度至重度舒张功能障碍：重度主动脉瓣狭窄患者一种新的多普勒超声心动图长期预后因素。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):890-6. doi: 10.1016/j.jtcvs.2004.09.004.
2
Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.血管紧张素转换酶抑制剂雷米普利对轻至中度主动脉瓣狭窄且左心室功能保留患者的血流动力学影响。
J Investig Med. 2004 Apr;52(3):185-91. doi: 10.1136/jim-52-03-33.
3
Predictable changes in left ventricular mass and function during ten years after valve replacement for aortic stenosis.主动脉瓣狭窄瓣膜置换术后十年期间左心室质量和功能的可预测变化。
J Heart Valve Dis. 2004 May;13(3):357-68.
4
Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).血管紧张素转换酶抑制剂在有症状的重度主动脉瓣狭窄中的安全性和有效性：有症状的心脏梗阻——依那普利治疗主动脉瓣狭窄的初步研究（SCOPE-AS）
Am Heart J. 2004 Apr;147(4):E19. doi: 10.1016/j.ahj.2003.10.017.
5
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.硝普钠用于左心室功能不全和主动脉瓣狭窄的危重病患者。
N Engl J Med. 2003 May 1;348(18):1756-63. doi: 10.1056/NEJMoa022021.
6
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.抑制体内压力超负荷肥大的基因改变可预防心脏功能障碍，尽管壁应力增加。
Circulation. 2002 Jan 1;105(1):85-92. doi: 10.1161/hc0102.101365.
7
Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.升主动脉缩窄及血管紧张素转换酶抑制大鼠心力衰竭的发展
Br J Pharmacol. 2000 Aug;130(7):1671-7. doi: 10.1038/sj.bjp.0703467.
8
Age dependency of left ventricular diastolic function in pressure overload hypertrophy.压力超负荷性肥厚中左心室舒张功能的年龄依赖性
J Am Coll Cardiol. 1997 Jan;29(1):181-6. doi: 10.1016/s0735-1097(96)00440-8.
9
Relation of phasic coronary flow velocity profile to clinical and hemodynamic characteristics of patients with aortic valve disease.主动脉瓣疾病患者的阶段性冠状动脉血流速度剖面与临床及血流动力学特征的关系。
Circulation. 1993 Sep;88(3):953-60. doi: 10.1161/01.cir.88.3.953.
10
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.血管紧张素转换酶抑制可延长因升主动脉狭窄导致压力超负荷肥大的大鼠的生存期，并改变其向心力衰竭的转变。
Circulation. 1994 Sep;90(3):1410-22. doi: 10.1161/01.cir.90.3.1410.
Zotero 插件